Decentralised Clinical Trials
Tuesday 14th July 2026 2pm GMT (15:00 CET and 9.00 EST)

Since COVID-19, decentralised clinical trials are reshaping how clinical trials are conducted - expanding participant access, improving data quality, and introducing new operational and regulatory considerations for sponsors and sites. Join us for an in‑depth 1-hour webinar designed specifically for clinical research professionals who want to strengthen their understanding of decentralised models while maintaining the highest standards of compliance, participant protection and date integrity.

This session will explore the regulatory expectations, and practical oversight expectations and strategies for decentralised trials, focusing on ICH E6(R3) Annex 1 and the draft ICH E6(R3) Annex 2.

The webinar is ideal for anyone interested in the design, set up, conduct, monitoring, auditing, and analysis of decentralised clinical trials involving medicinal products globally, including researchers, sponsors, CROs, consultants, healthcare professionals, clinical trial sites, R&D departments, and service providers.  Whether you are refining your decentralised trial processes or preparing to launch your first hybrid or fully decentralised study, this webinar will equip you with the knowledge and confidence to navigate decentralisation with confidence.

Prior basic knowledge of basic GCP is advised but not essential. The course will consist of presentations, and poll questions.  

Our normal webinar pricing applies:

• Individual connections (single participant): £200
• Single connection with up to 5 people taking part – note one connection only): £350
• Single connection with 5+ people taking part – note one connection only): £500
• Special rates available for organisations needing multiple connections - please contact us for details